v3.22.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Jan. 29, 2022
Jan. 30, 2021
Cash flows from operating activities:    
Net income (loss) $ (11,121,000) $ 4,277,000
Loss from discontinued operations   (124,000)
Income (loss) from continuing operations (11,121,000) 4,401,000
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Depreciation and amortization of property and equipment 737,000 534,000
Amortization of intangibles 142,000 141,000
Accretion of debt discount 2,270,000 666,000
Non-cash interest   232,000
Provision for bad debts   90,000
Stock-based compensation 1,103,000 1,332,000
Gain on extinguishment of debt (3,139,000) (13,642,000)
Loss on disposal of fixed assets 8,000 7,000
Provision for obsolete inventory 353,000 493,000
Gain on derivative liability   (543,000)
Impairment of right of use assets   52,000
Change in operating assets and liabilities:    
Trade accounts receivable 22,000 490,000
Other accounts receivable (191,000) 229,000
Inventory (1,692,000) 408,000
Prepaid assets 38,000 462,000
Other assets (67,000) (56,000)
Accounts payable 684,000 2,876,000
Accrued expenses and other current liabilities 1,023,000 (79,000)
Operating lease right of use assets and lease liabilities 1,470,000 303,000
Net cash used in continuing operating activities (8,360,000) (1,604,000)
Net cash used in discontinued operating activities (133,000) (605,000)
Net cash used in operating activities (8,493,000) (2,209,000)
Cash flows from investing activities:    
Purchase of property and equipment (2,956,000) (1,035,000)
Proceeds from sale of property and equipment 26,000  
Net cash used in investing activities (2,930,000) (1,035,000)
Cash flows from financing activities:    
Proceeds from issuance of notes payable 9,408,000 3,098,000
Proceeds from issuance of notes payable to related party 4,000,000 400,000
Payment of notes payable (3,731,000) (825,000)
Payment of notes payable to related party (400,000)  
Proceeds from sale of common stock 2,000,000 226,000
Proceeds from warrant exercises 123,000  
Short-swing profit disgorgement 253,000  
Net cash provided by financing activities 11,653,000 2,899,000
Effect of exchange rate changes on cash, cash equivalents and restricted cash 7,000 22,000
Net increase (decrease) in cash, cash equivalents and restricted cash 237,000 (323,000)
Cash, cash equivalents and restricted cash, beginning of period 2,846,000 3,169,000
Cash, cash equivalents and restricted cash, end of period 3,083,000 2,846,000
Cash paid for interest 66,000 89,000
Cash paid for income taxes 33,000 27,000
Non-cash investing and financing activities:    
Conversion of account payable and accrued liabilities to equity 87,000 163,000
Conversion of notes payable and accrued interest to equity 1,045,000 6,615,000
Accounts receivable offset against conversion of accounts payable to equity   (228,000)
Record operating lease right-of-use assets and operating lease liabilities $ 5,148,000 $ 3,647,000